Group 1 - Fuda Alloy's controlling shareholder Wang Dawu plans to reduce his stake by up to 3% of the company's total shares, amounting to a maximum of 406.34 million shares, due to personal funding needs [1] - ST Songfa's subsidiary signed contracts for the construction of 17 vessels, with a total contract value between 1.6 billion to 1.8 billion USD [2] - Pairui Co. signed a technical cooperation agreement with a university to develop large-capacity power semiconductor devices and related power electronic modules, effective for three years [3] Group 2 - Shuangliang Energy indirectly participates in commercial aerospace projects, supplying heat exchangers for SpaceX's fuel production system, with orders totaling approximately 1.39 million CNY [4] - Hangya Technology plans to issue convertible bonds to raise up to 600 million CNY for various projects, including an intelligent manufacturing base in Malaysia [5] - Yuhua Development is publicly selling assets with a base price of 251 million CNY for residential properties [6] Group 3 - Penghui Energy plans to invest 2.1 billion CNY in a new battery production project in Zhengyang County, Henan Province, focusing on high-performance battery products [7] - Haige Communication's shareholder Yang Haizhou intends to reduce his stake by up to 0.1624% of the company's total shares [8] - Yaoshi Technology's controlling shareholder pledged 5.13% of shares to repay loans, with a pledge period from February 10, 2026, to February 2, 2027 [9][10] Group 4 - Hanyu Pharmaceutical received FDA approval for its drug Acetate Glatiramer Injection, used for treating relapsing multiple sclerosis [11] - Baiyao Tai's GoliMab Injection received EMA approval for various indications, including rheumatoid arthritis and ulcerative colitis [12] - Jiangxi Tungsten Equipment plans to issue A-shares to raise up to 1.882 billion CNY for acquisitions [13] Group 5 - Hesong New Materials expects to recognize asset impairment provisions between 23.6 million to 28.5 million CNY for 2025 [14] - ST Meichen's subsidiary is involved in two major lawsuits with a total amount of approximately 31.9 million CNY [15] - China Coal Energy reported a 7.3% year-on-year decline in coal sales for January 2026, with total sales of 20.05 million tons [16] Group 6 - Yida Co. plans to adjust its epoxy propylene derivative project, reducing the total investment from 845 million CNY to 642 million CNY [17] - Fosun Pharma's subsidiary received approval for a clinical trial of HLX15-SC for multiple myeloma treatment [18][19] - Yinfeng Communication's board members and executives have terminated their share reduction plan [20] Group 7 - Huazhong High-tech has waived its preferential purchase rights for a fund, extending the investment period from three to four years [21] - Warner Pharmaceuticals plans to participate in a national drug procurement program, with expected sales of 176 million CNY [22] - Changling Hydraulic announced a tender offer to acquire 12% of its shares at a price of 35.82 CNY per share [23] Group 8 - ST Chuan Zhi's stock may face delisting due to financial data falling below regulatory thresholds [24] - Tian Pharmaceutical and its subsidiaries are participating in a national drug procurement program, with expected sales of 323 million CNY [25] - China Metallurgical Group signed new contracts worth 73.65 billion CNY in January 2026 [26] Group 9 - Torus plans to invest 21.2 million CNY in a venture capital fund focused on artificial intelligence [27] - Shangwei Co. received a government subsidy of 1.764 million CNY, representing 10.79% of its net profit for 2024 [28] - Hanghua Co. reported a 21.97% decline in net profit for 2025, with total revenue of 1.249 billion CNY [29] Group 10 - Huaxia Bank reported a 1.72% decline in net profit for 2025, with total revenue of 91.914 billion CNY [30] - Guotou Fengle plans to transfer 51% of its stake in Hubei Fengle Ecological Fertilizer to optimize management [31] - Huaru Technology is co-investing in a fund with a total commitment of 20 million CNY [32] Group 11 - Jindike reported a loss of 173 million CNY for 2025, despite a 40.13% increase in revenue [33] - Zhenong Co. announced a 0.52% increase in shares held by a major shareholder [34] - Maike Audi plans to recognize asset impairment provisions of approximately 52.55 million CNY [35] Group 12 - Fuan Pharmaceutical's subsidiary is expected to be selected for a national drug procurement program, with projected sales of 680 million CNY [36] - Rundu Co. is participating in a national drug procurement program, with some products expected to be selected [37] - Changqing Co. has postponed its large-scale die-casting project to March 2027 due to customer requirements [38] Group 13 - Pan Asia Micro透 received a patent for a graphene-based automotive headlight defogging device [39] - Luan An Huan Neng reported a 17.1% increase in raw coal production for January 2026, totaling 5 million tons [40] - Guangji Pharmaceutical received a drug registration certificate for Mecobalamin Tablets [41] Group 14 - Ruifeng New Materials announced the resignation of its deputy general manager for personal reasons [42] - Zhiguang Electric's subsidiary signed a procurement contract for energy storage equipment worth 210.4 million CNY [43] - Youyan Powder Materials reported a 19.41% increase in net profit for 2025 [44] Group 15 - Jincheng reported a 22.2% increase in net profit for 2025, with total revenue of 253 million CNY [46]

保荐人（主承销商） 证券代码：688386 证券简称：泛亚微透 江苏泛亚微透科技股份有限公司 向特定对象发行股票 发行情况报告书 二〇二六年二月 发行人全体董事、审计委员会成员及高级管理人员声明 本公司全体董事、审计委员会成员及高级管理人员承诺本发行情况报告书不 存在虚假记载、误导性陈述或重大遗漏，并对其真实性、准确性、完整性承担相 应的法律责任。 全体董事签名： 张 云 李建革 王爱国 蒋 励 王玉新 陈宇峰 陈 强 钱技平 沈金涛 江苏泛亚微透科技股份有限公司 年 月 日 发行人全体董事、审计委员会成员及高级管理人员声明 本公司全体董事、审计委员会成员及高级管理人员承诺本发行情况报告书不 存在虚假记载、误导性陈述或重大遗漏，并对其真实性、准确性、完整性承担相 应的法律责任。 李建革 钱技平 沈金涛 江苏泛亚微透科技股份有限公司 年 月 日 发行人全体董事、审计委员会成员及高级管理人员声明 本公司全体董事、审计委员会成员及高级管理人员承诺本发行情况报告书不 存在虚假记载、误导性陈述或重大遗漏，并对其真实性、准确性、完整性承担相 应的法律责任。 全体高级管理人员签名： 全体审计委员会成员签名： 张 云 王爱国 ...

法律意见书 广东信达律师事务所 关于江苏泛亚微透科技股份有限公司 2025 年度向特定对象发行 A 股股票发行过程和认购对象合规 性的法律意见书 | 目录 | | --- | | 释义 | 2 | | --- | --- | | 信达律师声明事项 | 5 | | 正文 | 7 | | 第一节 发行人本次发行的批准和授权 | 7 | | 第二节 本次发行的发行过程与结果 | 8 | | 第三节 本次发行认购对象的合规性 | 13 | | 第四节 本次发行的总体结论性意见 | 16 | 中国深圳福田区益田路6001号太平金融大厦11、12楼邮政编码：518038 11、12F,TaiPingFinanceTower,YitianRoad6001,FutianDistrict,ShenZhen,China 电话（Tel.）：（0755）88265288传真（Fax.）:（0755）88265537 网站：www.sundiallawfirm.com 法律意见书 （《法律意见书》中如部分数据的合计数与各单项数据加总数存在微小差异，系由计算过程中 四舍五入造成） 3 法律意见书 释义 在《法律意见书》中，除上下文另有解 ...

| | | | …………………… 第 3—20 页 ニ、 附件 | | --- | | (一)注册资本及实收股本变更前后对照表 …………………………… 第 3 页 | | (二) 验资事项说明 ………………………… …………… 第 4―5 页 | | (三) 银行询证函复印件 ………………第 6-16 页 | | (四) 本所营业执照复印件 ………………… ……………第 17 页 | | (五) 本所执业证书复印件 …………第 18 页 | | （六） 签字注册会计师执业证书复印件 …………………… …… 第 19-20 页 | 验 资 报 告 天健验〔2026〕57 号 江苏泛亚微透科技股份有限公司： 我们接受委托，审验了贵公司截至 2026 年 2 月 5 日止的新增注册资本及实 收股本情况。按照法律法规以及协议、章程的要求出资，提供真实、合法、完整 的验资资料，保护资产的安全、完整是全体出资者及贵公司的责任。我们的责任 是对贵公司新增注册资本及实收股本情况发表审验意见。我们的审验是依据《中 国注册会计师审计准则第 1602 号——验资》进行的。在审验过程中，我们结合 贵公司的实际情况，实施了检查等必要的 ...

证券代码：688386 证券简称：泛亚微透 国泰海通证券股份有限公司 关于江苏泛亚微透科技股份有限公司 向特定对象发行股票 发行过程和认购对象合规性报告 保荐人（主承销商） 二〇二六年二月 江苏泛亚微透科技股份有限公司（以下简称"泛亚微透"、"发行人"、"上 市公司"或"公司"）向特定对象发行股票（以下简称"本次发行"）已获得中 国证券监督管理委员会（以下简称"中国证监会"）证监许可〔2026〕82 号文 同意注册。 泛亚微透本次向特定对象发行股票的保荐人（主承销商）为国泰海通证券股 份有限公司（以下简称"保荐人（主承销商）"、"主承销商"或"国泰海通"）。 （一）发行股票的种类和面值 本次向特定对象发行的股票种类为境内上市的人民币普通股（A 股），每股 面值人民币 1.00 元。 （二）发行数量 根据发行人及主承销商向上交所报送的《发行方案》，本次拟发行的股份数 量为不超过本次拟募集金额总额 67,149.88 万元/发行底价 73.24 元/股所计算的股 数 9,168,470 股与《募集说明书》中载明的"本次向特定对象发行股票的数量不 超过本次发行前公司总股本的 30%，即本次发行不超 27,300,0 ...

关于获得发明专利的自愿性披露公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真性、准确性和完整性承担个别及连带责任。 江苏泛亚微透科技股份有限公司（以下简称"公司"或"泛亚微透"）于近 日收到了一项国家知识产权局颁发的授权发明专利证书，具体如下： 证券代码：688386 证券简称：泛亚微透 公告编号：2026-004 江苏泛亚微透科技股份有限公司 | 发明专利名称 | 专利号 | 专利申请日 | 授权公告日 | 专利 | 专利期限 | | --- | --- | --- | --- | --- | --- | | | | | | 权人 | | | 汽车车灯除雾 | | | | | | | 用石墨烯碳导 | | | | | | | | | | | | 20 年（自 | | 热片与可逆型 | | | | 泛亚 | | | | ZL202510196939.8 | 2025.02.21 | 2026.01.30 | | 申 请 日 起 | | 干燥剂膜片组 | | | | 微透 | | | | | | | | 算) | | 合的膜组件及 | | | | | | | ...

证券代码：688386 证券简称：泛亚微透 公告编号：2026-003 江苏泛亚微透科技股份有限公司 关于开立募集资金专项账户并签订募集资金专户存储 三方监管协议的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担个别及连带责任。 一、募集资金基本情况 三、《募集资金专户存储三方监管协议》的主要内容 1、工商银行 （一）实际募集资金金额、资金到位情况 经中国证券监督管理委员会出具的《关于同意江苏泛亚微透科技股份有限公 司向特定对象发行股票注册的批复》（证监许可〔2026〕82 号），江苏泛亚微透 科技股份有限公司（以下简称"公司"或 "泛亚微透"）向特定对象发行人民币 普通股(A 股)8,608,958 股，每股面值人民币 1.00 元，发行价格为 78.00 元/股， 募集资金总额为人民币 671,498,724.00 元，扣除不含增值税发行费用人民币 6,938,679.22 元，实际募集资金净额为人民币 664,560,044.78 元。 上述募集资金已于 2026 年 2 月 5 日到位，经天健会计师事务所（特殊普通 合伙）审 ...

证券代码：688386 证券简称：泛亚微透 公告编号：2026-002 本 次 发 行 的 具 体 情 况 详 见 公 司 同 日 披 露 于 上 海 证 券 交 易 所 网 站 (www.sse.com.cn)的《江苏泛亚微透科技股份有限公司向特定对象发行股票发行 情况报告书》等相关文件。 特此公告。 江苏泛亚微透科技股份有限公司 董事会 2026 年 2 月 13 日 江苏泛亚微透科技股份有限公司 关于向特定对象发行股票发行情况的提示性的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担个别及连带责任。 江苏泛亚微透科技股份有限公司（以下简称"公司"）2025 年度向特定对 象发行 A 股股票（以下简称"本次发行"）发行承销总结及相关文件已经上海证 券券交易所备案通过，公司将根据相关规定尽快办理本次发行新增股份的登记托 管事宜。 ...

Core Viewpoint - The company has received a patent for a graphene-based component aimed at improving automotive lighting defogging, which enhances its intellectual property portfolio and supports technological innovation [1] Group 1: Patent Details - The patent is titled "Graphene Carbon Heat Conductive Sheet and Reversible Desiccant Membrane Combination for Automotive Lighting Defogging" [1] - The patent number is ZL202510196939.8, with an application date of February 21, 2025, and an announcement date of January 30, 2026 [1] - The patent is granted for a duration of 20 years [1] Group 2: Impact on the Company - The patent is not expected to have a significant immediate impact on the company's operations [1] - It contributes to the enhancement of the company's intellectual property protection system [1] - The patent is anticipated to promote technological innovation and improve the company's core competitiveness [1]

Core Viewpoint - The company has received a granted invention patent from the National Intellectual Property Administration for a technology related to automotive lighting defogging, which reflects the company's core technological capabilities and enhances its intellectual property protection system [1] Group 1 - The patent is titled "Graphene Carbon Heat Conductive Sheet and Reversible Desiccant Membrane Combination for Automotive Lighting Defogging" [1] - The patent application date is February 21, 2025, and the authorization announcement date is January 30, 2026, with a validity period of 20 years [1] - Although the patent will not have a significant impact on the company's short-term operations, it is expected to promote technological innovation and enhance core competitiveness [1]